{Reference Type}: Journal Article
{Title}: The Role of Microbiota in Pancreatic Cancer.
{Author}: Papa V;Schepis T;Coppola G;Chiappetta MF;Del Vecchio LE;Rozera T;Quero G;Gasbarrini A;Alfieri S;Papa A;
{Journal}: Cancers (Basel)
{Volume}: 15
{Issue}: 12
{Year}: 2023 Jun 11
{Factor}: 6.575
{DOI}: 10.3390/cancers15123143
{Abstract}: Pancreatic cancer (PC) has an unfavorable prognosis with few effective therapeutic options. This has led researchers to investigate the possible links between microbiota and PC. A disrupted gut microbiome can lead to chronic inflammation, which is involved in the pathogenesis of PC. In addition, some bacterial strains can produce carcinogens that promote the growth of cancer cells. Research has also focused on pancreatic and oral microbiota. Changes in these microbiota can contribute to the development and progression of PC. Furthermore, patients with periodontal disease have an increased risk of developing PC. The potential use of microbiota as a prognostic marker or to predict patients' responses to chemotherapy or immunotherapy is also being explored. Overall, the role of microbiota-including the gut, pancreatic, and oral microbiota-in PC is an active research area. Understanding these associations could lead to new diagnostic and therapeutic targets for this deadly disease.